| Predicate |
Object |
| contentType |
Clinical Trial|Clinical Trial, Phase II|Journal Article|Multicenter Study|Research Support, U.S. Gov't, P.H.S. |
| endingPage |
349 |
| issn |
1573-0646
0167-6997 |
| issueIdentifier |
3 |
| pageRange |
343-349 |
| publicationName |
Investigational New Drugs |
| startingPage |
343 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_39ee30eeb1a73a6ccf5c22db5eb14e99
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7f8fd5217e5944e2ed7b3c47b0d35207 |
| bibliographicCitation |
Schilder RJ, Blessing JA, Pearl ML, Rose PG. Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group. Invest New Drugs. 2004 Aug;22(3):343–9. doi: 10.1023/b:drug.0000026262.77502.31. PMID: 15122083. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a56d0ec4128e6bb51dcc1fffeb7f3195
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f6a5f6c1ac55c8ced644a8713a75350
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae7389546cc9da54731802b22e7fa2c3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32254a8d829abc043971a7caffca54da |
| date |
200408 |
| identifier |
https://doi.org/10.1023/b:drug.0000026262.77502.31
https://pubmed.ncbi.nlm.nih.gov/15122083 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0167-6997
https://portal.issn.org/resource/ISSN/1573-0646
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4372 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group |
| discusses |
http://id.nlm.nih.gov/mesh/M0268775
http://id.nlm.nih.gov/mesh/M0028268
http://id.nlm.nih.gov/mesh/M0019703 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10923
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148189
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9950
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9627 |